Changes in oxygenation of intracranial tumors with carbogen: A BOLD MRI and EPR oximetry study

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 5, 2002, Pages 511-521

  Dunn, Jeff F ^a,b   O'Hara, Julia A ^a   Zaim Wadghiri, Youssef ^a   Lei, Hao ^a   Meyerand, M Elizabeth ^a   Grinberg, Oleg Y ^a   Hou, Huagang ^a   Hoopes, P Jack ^a   Demidenko, Eugene ^a   Swartz, Harold M ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

BOLD; Brain tumor; EPR; Oxygenation; pO2 carbogen

Indexed keywords

CARBOGEN; LITHIUM DERIVATIVE; PHTHALOCYANINE DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; INTRACRANIAL TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; OXYGEN BLOOD LEVEL; OXYGEN BREATHING; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; RAT; SARCOMA; TISSUE OXYGENATION;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON DIOXIDE; ELECTRON SPIN RESONANCE SPECTROSCOPY; MAGNETIC RESONANCE IMAGING; NEOPLASM TRANSPLANTATION; OXIMETRY; OXYGEN; RADIATION-SENSITIZING AGENTS; RATS; RATS, INBRED LEW; TUMOR CELLS, CULTURED;

EID: 0036828969     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10192     Document Type: Article

References (50)

1. Veninga T, Langendijk HA, Slotman BJ, et al. Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors. Radiother Oncol 2001;59:127-137.
2. Hockel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515.
3. Overgaard J, Horsman MR. Modification of hypoxia-induced radio-resistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6:10-21.
4. Okunieff P, Hoeckel M, Dunphy EP, et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1993;26:631-636.
5. 2 measurements by EPR oximetry. Radiat Res 1998;150:549-556.
6. Wheeler KT, Wallen CA. Is cell survival a determinant of the in situ response of 9L tumours? Br J Cancer (Suppl) 1980;41:299-303.
7. Teicher BA, Holden SA, Menon K, et al. Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents. Cancer Chemother Pharmacol 1993; 33:57-62.
8. Teicher BA, Herman TS, Rose CM. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU. Int J Radiat Oncol Biol Phys 1988;15:1187-1192.
9. Kayama T, Yoshimoto T, Fujimoto S, et al. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 1991;74:55-59.
10. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 1994;29:427-431.
11. Collingridge DR, Piepmeier JM, Rockwell S, et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 1999;53:127-131.
12. Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-117.
13. Ogawa S, Lee TM, Kay AR, et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868-9872.
14. Robinson S, Howe F, Griffiths J. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1995;33:855-859.
15. 2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed 1994;7:3-11.
16. Robinson SP, Rodrigues LM, Ojugo AS, et al. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 1997;75:1000-1006.
17. Dunn JF, Swartz HM. Blood oxygenation: Heterogeneity of hypoxic tissue monitored using BOLD MR imaging. Adv Exp Med Biol 1996; 428:645-650.
18. Vexler VS, de Crespigny AJ, Wendland MF, et al. MR imaging of blood oxygenation-dependent changes in focal renal ischemia and transplanted liver tumor in rat. J Magn Reson Imaging 1993;3:483-490.
19. Oikawa H, Al-Hallaq HA, Lewis MZ, et al. Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med 1997;38:27-32.
20. Peller M, Weissfloch L, Stehling MK, et al. Oxygen-induced MR signal changes in murine tumors. Magn Reson Imaging 1998;16:799-809.
21. van der Sanden BP, Heerschap A, Hoofd L, et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med 1999;42:490-499.
22. Al-Hallaq HA, River JN, Zamora M, et al. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Rad Oncol Biol Phys 1998;41:151-159.
23. Griffiths JR, Taylor NJ, Howe FA, et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;39:697-701.
24. Mazurchuk R, Zhou R, Straubinger RM, et al. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: Implications for evaluation of tumor microvasculature and therapeutic response. Magn Reson Imaging 1999;17:537-548.
25. 2 in a RIF-1 tumor. Magn Reson Med 1995;34:515-519.
26. Goda F, O'Hara JA, Rhodes ES, et al. Changes of oxygen tension in experimental tumors after a single dose of x-ray irradiation. Cancer Res 1995;55:2249-2252.
27. Rolett EL, Azzawi A, Liu KJ, et al. Critical oxygen tension in rat brain: A combined 31P-NMR and EPR oximetry study. Am J Physiol 2000;279:R9-R16.
28. Dunn JF, Grinberg O, Roche M, et al. Non-invasive assessment of cerebral oxygenation during acclimation to hypobaric hypoxia. J Cereb Blood Flow Metab 2000;20:1632-1635.
29. Kruse CA, Molleston MC, Parks EP, et al. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: A comparison to 9L gliosarcoma. J Neurooncol 1994;22:191-200.
30. Dunn JF, Zaim Wadghiri Y, Meyerand ME. Regional heterogeneity of the brain's response to hypoxia measured using BOLD MR imaging. Magn Reson Med 1999;41:850-854.
31. Bates S, Yetkin Z, Jesmanowicz A, et al. Artifacts in functional magnetic resonance imaging from gaseous oxygen. J Magn Reson Imaging 1995;5:443-445.
32. Rostrup E, Law I, Blinkenberg M, et al. Regional differences in the CBF and BOLD responses to hypercapnia: A combined PET and fMRI study. Neuroimage 2000;11:87-97.
33. Taylor NJ, Stirling JJ, Culver LA, et al. Perfusion changes in normal brain due to breathing carbogen and oxygen: an MRI study. In: Proceedings of the 8th Annual Meeting of ISMRM. Denver, 2000. p. 97.
34. 2. Neurobiol Aging 1982;3:141-143.
35. Cartheuser CF. Standard and pH-affected hemoglobin-O2 binding curves of Sprague-Dawley rats under normal and shifted P50 conditions. Comp Biochem Physiol Comp Physiol 1993;106:775-782.
36. Robinson SP, Rodrigues LM, Howe FA, et al. Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. Magn Reson Imaging 2001;19:161-166.
37. 2* with response to radiotherapy. In: Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, Scotland. 2001. p 637.
38. Rijpkema M, Kaanders J, van der Kogel A, et al. Effects of carbogen breathing on tissue oxygenation and perfusion in head and neck tumors as measured by MRI. In: Proceedings of the 9th Annual Meeting of ISMRM. Glasgow. Scotland. 2001. p 633.
39. Zaim Wadghiri Y, O'Hara JA, Grinberg OY, et al. NMR and EPR studies of BOLD contrast and oxygenation in tumors: measurement of pO2 and T2* response after carbogen breathing. In: Proceedings of the 5th Annual Meeting of ISMRM, Vancouver. Canada. 1997. p 2082.
40. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 2001;14:156-163.
41. 2 histography. Br J Cancer 1992;66:919-924.
42. Hill SA, Collingridge DR, Vojnovic B, et al. Tumour radiosensitization by high-oxygen-content gases: Influence of the carbon dioxide content of the inspired gas on PO2. microcirculatory function and radiosensitivity. Int J Radiat Oncol Biol Phys 1998;40:943-951.
43. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-836.
44. Al-Hallaq HA, Fan X, Zamora M, et al. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed 2002;15:28-36.
45. Lebon V, Carlier PG, Brillault-Salvat C, et al. Simultaneous measurement of perfusion and oxygenation changes using a multiple gradient-echo sequence: Application to human muscle study. Magn Reson Imaging 1998;16:721-729.
46. Speck O, Ernst T, Chang L. Biexponential modeling of multigradient-echo MRI data of the brain. Magn Reson Med 2001;45:1116-1121.
47. Martin LM, Thomas CD, Guichard M, Nicotinamide and carbogen: Relationship between pO2 and radiosensitivity in three tumour lines. Int J Radiat Biol 1994;65:379-386.
48. Jordan BF, Misson P, Demeure R, et al. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: Monitoring by EPR and MRI. Int J Radiat Oncol Biol Phys 2000;48:565-570.
49. Maxwell RJ, Robinson SP, McIntyre DJO, et al. Comparison of changes in gradient-echo 1H MRimage intensity and pO2 in rodent tumours in response to carbogen breathing. In: Proceedings of the 7th Annual Meeting of ISMRM. Philadelphia. 1999. p 495.
50. Brizel DM, Lin S, Johnson JL, et al. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. Br J Cancer 1995;72:1120-1124.